General Information of the Compound
Compound ID
CP0862524
Compound Name
(E)-3-(4-((2-((1-(4-Chlorobenzyl)piperidin-4-yl)amino)thieno[3,2-d]pyrimidin-4-yl)oxy)-3,5-dimethylphenyl)acrylonitrile
    Show/Hide
Structure
Formula
C29H28ClN5OS
Molecular Weight
530.097
Canonical SMILES
Cc1cc(/C=C/C#N)cc(C)c1Oc1nc(NC2CCN(Cc3ccc(Cl)cc3)CC2)nc2ccsc12
    Show/Hide
InChI
InChI=1S/C29H28ClN5OS/c1-19-16-22(4-3-12-31)17-20(2)26(19)36-28-27-25(11-15-37-27)33-29(34-28)32-24-9-13-35(14-10-24)18-21-5-7-23(30)8-6-21/h3-8,11,15-17,24H,9-10,13-14,18H2,1-2H3,(H,32,33,34)/b4-3+
    Show/Hide
InChIKey
UCBQBGKYOOSEBV-ONEGZZNKSA-N
Physicochemical Property
logP
7.36712
Rotatable Bonds
7
Heavy Atom Count
37
Polar Areas
74.07
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
7
Complexity
37

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 129909019
ChEMBL ID
CHEMBL4076005
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00005, Reverse transcriptase/RNaseH
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000247 MT-4 Homo sapiens (Human)  7
1
EC50 = 25 nM
   TI
   LI
   LO
   TS
2
EC50 = 42.8 nM
   TI
   LI
   LO
   TS
3
EC50 = 77.7 nM
   TI
   LI
   LO
   TS
4
EC50 = 108 nM
   TI
   LI
   LO
   TS
5
EC50 = 152 nM
   TI
   LI
   LO
   TS
6
EC50 = 177 nM
   TI
   LI
   LO
   TS
7
EC50 = 195 nM
   TI
   LI
   LO
   TS
Cell Viability or Cytotoxicity Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000247 MT-4 Homo sapiens (Human)  1
1
CC50 = 3980 nM
   TI
   LI
   LO
   TS